Clorox (NYSE:CLX – Free Report) had its price target reduced by Evercore ISI from $145.00 to $142.00 in a research note issued to investors on Wednesday morning, Benzinga reports. Evercore ISI currently has an underperform rating on the stock. Other analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. upped […]
Clorox (NYSE:CLX – Free Report) had its target price lowered by JPMorgan Chase & Co. from $159.00 to $158.00 in a research note released on Wednesday morning, Benzinga reports. The firm currently has a neutral rating on the stock. Several other research firms have also issued reports on CLX. Citigroup reduced their target price on […]
Clorox (NYSE:CLX – Free Report) had its target price reduced by Barclays from $136.00 to $132.00 in a research report report published on Thursday morning, Benzinga reports. They currently have an underweight rating on the stock. A number of other equities research analysts have also weighed in on CLX. Morgan Stanley restated an equal weight […]
Clorox (NYSE:CLX – Free Report) had its price objective cut by Citigroup from $155.00 to $150.00 in a research note issued to investors on Wednesday, Benzinga reports. They currently have a neutral rating on the stock. A number of other brokerages have also commented on CLX. Deutsche Bank Aktiengesellschaft dropped their target price on Clorox […]
Glassman Wealth Services trimmed its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 37.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 193 shares of the company’s stock after selling 116 shares during the period. Glassman Wealth […]